What happens to the clinical trial data?
Researchers review the clinical trial data after each phase to determine if the next phase should begin. After Phase III has been completed and the treatment judged to be safe, effective, and an improvement upon existing treatments, the treatment is submitted for review by the FDA. The FDA may then approve the treatment for use in the general public or mandate that additional research be conducted. Results of clinical trials are sometimes published in medical journals.
